Cite
MLA Citation
M. Heuser et al.. “P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION.” HemaSphere, vol. 6, n.d., pp. 1338–1339. http://access.bl.uk/ark:/81055/vdc_100159757324.0x000009